MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-PB-12-0019271
Aripolis Biotech Private Limited - pharma in Ludhiana, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.45 Cr
▲ 10% YoY
Net profit · FY 2025
₹13.99 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹69.16 Lakh
EBITDA margin 12.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.4 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
7
Provident fund records
About Aripolis Biotech Private Limited
Data last updated:
Aripolis Biotech Private Limited is a private limited company based in Ludhiana, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 May 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2014PTC038615. Its GSTIN is 03AAMCA6706A1Z7 (Punjab).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Tiwari and Vishal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village Ajnoud Tehsil Payal, Ludhiana, Punjab, India – 141421.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.45 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹13.99 Lakh (net margin 2.6%) and EBITDA of ₹69.16 Lakh (EBITDA margin 12.7%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 4% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.4 Cr on record.
Aripolis Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-12-0019271). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aripolisbiotech.com.
Company details
CIN U24232PB2014PTC038615
Registration Number 038615
Incorporation Date 22 May 2014
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PB-12-0019271
Key People
Amit Tiwari Director Vishal Director Recognitions & Rankings of Aripolis Biotech
Contact details
Aripolis Biotech Private Limited's registered office is in Ludhiana, Punjab. Its website is aripolisbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVillage Ajnoud Tehsil Payal, Ludhiana, Punjab, India – 141421
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aripolis Biotech Private Limited, buy the company report.
Comprehensive company report
Aripolis Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aripolis Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aripolis Biotech Private Limited, buy the company report.
Financials of Aripolis Biotech Private Limited
FY 2025 filings availableAripolis Biotech Private Limited reported revenue of ₹5.45 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹5.45 Cr ▲ 10%
Net profit · FY 2025
₹13.99 Lakh margin 2.6%
EBITDA · FY 2025
₹69.16 Lakh margin 12.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▼ 24%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 6%
5 years · compounded
▲ 10%
Revenue rose 10% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹69.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.7% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aripolis Biotech Private Limited, buy the company report.
Board of directors of Aripolis Biotech Private Limited
Aripolis Biotech has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Tiwari | Director | 24 Aug 2023 | 3 Years 2 Months | Current |
| Vishal | Director | 01 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Aripolis Biotech Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arient Scientific Private Limited | ₹5.46 Cr (FY 2016) | 35.0% | Thane, Maharashtra, India | |||
| A B S Remedies Private Limited | ₹5.45 Cr (FY 2025) | -2.0% | New Delhi, Delhi, India | |||
| Suntril Pharmaceuticals Private Limited | ₹5.45 Cr (FY 2024) | 19.0% | Chandigarh, India | |||
| Aripolis Biotech Private Limitedthis company | ₹5.45 Cr (FY 2025) | ₹13.99 Lakh | 2.6% | 10.0% | 7 | Ludhiana, Punjab, India |
| Rako Agrochem Private Limited | ₹5.43 Cr (FY 2025) | 9.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Aripolis Biotech Private Limited, buy the company report.
Auditor
Aripolis Biotech Private Limited is audited by LAL & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LAL & ASSOCIATES | FY 2024 | 009392N |
Shareholding
The shareholding of Aripolis Biotech Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aripolis Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.4 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 May 2019 | 100288427 | Hdfc Bank Limited | ₹1 Cr | Open | |
| 31 Mar 2015 | 10564480 | Indian Overseas Bank | ₹40 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Aripolis Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aripolis Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aripolis Biotech Private Limited has a workforce of 7 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.
Employee count
7
Active EPFO establishments
1
Employee growth
16.67%
GST
Aripolis Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAMCA6706A1Z7 | Punjab | Active | 14 Jul 2017 |
To see the full GST registrations and return filing status of Aripolis Biotech Private Limited, buy the company report.
Recent activity
Aripolis Biotech Private Limited has 8 board changes on record since 2017: 2 appointments and 6 cessations. The latest: Amit Tiwari was appointed as Director on 24 Aug 2023.
AGM
Aripolis Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aripolis Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Amit Tiwari was appointed as Director.
Ceased
Yogender Kumar ceased to be Director.
Ceased
Simarjit Singh ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 100288427 was registered on 17 May 2019.
Ceased
Labhnesh Jindal ceased to be Director.
Ceased
Sushila Kumari ceased to be Director.
Ceased
Vishal ceased to be Additional Director.
Appointed
Vishal was appointed as Director.
Ceased
Krishan Lal ceased to be Director.
Charges
A charge with Indian Overseas Bank amounted to Rs. 40.00 Lakh with Charge ID 10564480 was registered on 31 Mar 2015.
1 earlier event is in the company report.
Frequently asked questions
Aripolis Biotech is an active private limited company based in Ludhiana, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 May 2014 (12+ years old) and is registered under CIN U24232PB2014PTC038615.
Aripolis Biotech has 2 current directors:
- Amit Tiwari - Director
- Vishal - Director
The latest financial statements of Aripolis Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aripolis Biotech is 03AAMCA6706A1Z7, registered in Punjab.
The CIN (Corporate Identification Number) of Aripolis Biotech is U24232PB2014PTC038615. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aripolis Biotech was incorporated on 22 May 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Aripolis Biotech by revenue are Arient Scientific Private Limited, A B S Remedies Private Limited, Suntril Pharmaceuticals Private Limited, Rako Agrochem Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amit Tiwari was appointed as Director on 24 Aug 2023. Yogender Kumar ceased to be Director on 17 Aug 2023. Simarjit Singh ceased to be Director on 05 Jun 2019. Aripolis Biotech has 8 board changes on record in total.
Yes, Aripolis Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-PB-12-0019271).
Aripolis Biotech can be reached through the website aripolisbiotech.com. Its registered office is in Ludhiana, Punjab, India.
The registered office of Aripolis Biotech is at Village Ajnoud Tehsil Payal, Ludhiana, Punjab, India – 141421.